Metabolic PET/CT analysis of aggressive Non-Hodgkin lymphoma prior to Axicabtagene Ciloleucel CAR-T infusion: predictors of progressive disease, survival, and toxicity.
Blood Cancer J
; 13(1): 127, 2023 08 18.
Article
in En
| MEDLINE
| ID: mdl-37591834
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphoma, Non-Hodgkin
/
Receptors, Chimeric Antigen
Type of study:
Diagnostic_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Blood Cancer J
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: